Allegion (NYSE:ALLE) Upgraded to “Buy” at Bank of America

Allegion (NYSE:ALLE) was upgraded by investment analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued to investors on Friday, MarketBeat reports. The brokerage currently has a $200.00 target price on the scientific and technical instruments company’s stock, up from their prior target price of $164.00. Bank of America‘s target price points to a potential upside of 13.63% from the stock’s previous close.

ALLE has been the subject of several other reports. Robert W. Baird set a $170.00 target price on shares of Allegion in a research note on Friday, July 24th. JPMorgan Chase & Co. increased their price target on Allegion from $150.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, July 24th. Weiss Ratings upgraded Allegion from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Finally, Evercore restated an “outperform” rating and set a $180.00 price objective on shares of Allegion in a report on Tuesday, September 22nd. Four analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Allegion has an average rating of “Moderate Buy” and an average price target of $167.88.

Allegion Trading Up 10.7%

Shares of ALLE stock opened at $176.01 on Friday. The company has a market capitalization of $14.97 billion, a price-to-earnings ratio of 23.10, a PEG ratio of 3.23 and a beta of 0.81. The company has a current ratio of 1.93, a quick ratio of 1.23 and a debt-to-equity ratio of 0.96. The firm has a 50-day moving average price of $156.04 and a 200 day moving average price of $146.13. Allegion has a twelve month low of $125.00 and a twelve month high of $183.11.

Allegion (NYSE:ALLE) last posted its quarterly earnings data on Thursday, October 22nd. The scientific and technical instruments company reported $2.60 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.10. The business had revenue of $1.17 billion during the quarter, compared to analyst estimates of $1.14 billion. Allegion had a net margin of 15.36% and a return on equity of 35.41%. The company’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.30 earnings per share. Research analysts forecast that Allegion will post 8.94 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Steven Mizell acquired 170 shares of the stock in a transaction dated Friday, August 28th. The stock was bought at an average cost of $158.28 per share, with a total value of $26,907.60. Following the purchase, the director directly owned 5,899 shares of the company’s stock, valued at approximately $933,693.72. This represents a 2.97% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Timothy P. Eckersley sold 6,417 shares of the company’s stock in a transaction on Monday, July 27th. The stock was sold at an average price of $157.26, for a total value of $1,009,137.42. Following the sale, the senior vice president owned 29,919 shares of the company’s stock, valued at approximately $4,705,061.94. The trade was a 17.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Allegion

Institutional investors have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Allegion by 5,141.6% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 11,846 shares of the scientific and technical instruments company’s stock valued at $1,822,000 after purchasing an additional 11,620 shares in the last quarter. Regents Gate Capital LLP grew its holdings in shares of Allegion by 291.7% during the 1st quarter. Regents Gate Capital LLP now owns 165,622 shares of the scientific and technical instruments company’s stock worth $24,063,000 after purchasing an additional 123,343 shares during the period. Andra AP fonden grew its holdings in shares of Allegion by 382.8% during the 2nd quarter. Andra AP fonden now owns 69,945 shares of the scientific and technical instruments company’s stock worth $9,827,000 after purchasing an additional 55,459 shares during the period. GAMMA Investing LLC increased its position in Allegion by 1,653.5% during the 3rd quarter. GAMMA Investing LLC now owns 33,018 shares of the scientific and technical instruments company’s stock worth $5,077,000 after purchasing an additional 31,135 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in Allegion by 19.4% during the 1st quarter. The Manufacturers Life Insurance Company now owns 599,326 shares of the scientific and technical instruments company’s stock worth $87,076,000 after purchasing an additional 97,304 shares in the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

Trending Headlines about Allegion

Here are the key news stories impacting Allegion this week:

• Positive Sentiment: Quarterly results exceeded expectations: Allegion reported adjusted earnings of $2.60 per share, above the $2.50 consensus estimate, while revenue rose 9.6% year over year to $1.17 billion, surpassing forecasts of approximately $1.14 billion. Earnings also increased from $2.30 per share in the prior-year quarter. Allegion third-quarter earnings report
• Positive Sentiment: Management raised its 2026 guidance: Allegion now expects reported revenue growth of 9.5% to 10.5% and adjusted earnings of $9.05 to $9.10 per share. The higher outlook signals that management sees the recent demand and margin trends continuing through the remainder of the year. Allegion raises 2026 outlook
• Positive Sentiment: Americas operations led the improvement: Organic revenue in the Americas non-residential business grew at a low-double-digit rate in the third quarter. Robust regional growth, pricing and margin expansion were key drivers of the earnings beat and helped offset softer conditions in some international markets. Allegion long-term investor takeaways
• Neutral Sentiment: The market’s positive reaction places Allegion near its 12-month high, with the stock trading above both its 50-day and 200-day moving averages. This reflects stronger investor expectations, but may also leave less room for disappointment if growth or guidance momentum slows.
• Negative Sentiment: International weakness remains a headwind, making Allegion’s performance increasingly dependent on sustained Americas demand. Investors will also monitor whether the company can maintain margin gains and meet the newly raised guidance.

About Allegion

Allegion plc (NYSE:ALLE) is a global security products and solutions company focused on protecting people and property. Its portfolio includes mechanical and electronic locks, access control systems, door closers, exit devices, door controls, and commercial doors and frames.

The company serves commercial, institutional, industrial, and residential customers through well-known brands including Schlage, Von Duprin, LCN, Steelcraft, Briton, and aptiQ. Its offerings range from traditional hardware to connected and electronic access solutions designed for offices, schools, healthcare facilities, multifamily properties, and homes.

Allegion was established as an independent public company in 2013 following its separation from Ingersoll Rand.